Dupixent Use in Treatment of Refractory Bullous Pemphigoid

Co-Authors:Jordan Beam, BS, MS3, UAB Heersink School of Medicine, Birmingham, AL; Jo Herzog, MD, Dermatology, Brookwood Dermatology, Birmingham, AL This presentation discusses a case where Dupixent was approved for use in refractory bullous pemphigoid. The patient was unable to finish the traditional treatment due to psychosis and anemia, and alternative agents did not resolve her condition. She only saw significant improvement in her condition after consistent Dupixent use.